Mechanistically, the early CRC-induced loss of local intestinal barrier integrity and the subsequent entry of microbial products into the tumor microenvironment relevantly trigger the activation of IL-23-producing intratumoral myeloid cells [125]. This evidence concerns the gene IL23A and colorectal carcinoma.